Digital Health Technology (DHT) Clinical Validation Research
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract seeks to conduct clinical investigations aimed at validating digital health technologies including actigraphy, contactless sensors, and photography for use in drug development trials. The goal is to assess the reliability and validity of these technologies as objective data sources to support regulatory decision-making and improve the efficiency of clinical research. The work will involve designing and executing studies that generate high-quality, reproducible data demonstrating how these tools can accurately capture physiological and behavioral biomarkers in real-world or controlled clinical settings. This is a subcontract under the Food and Drug Administration, part of the Department of Health and Human Services, governed by NAICS code 541715 for research and development in the physical, engineering, and life sciences. The opportunity was posted on July 20, 2026, with a response deadline of August 20, 2026. While no specific location or point of contact is provided, the performance location and administrative details will be defined in the subcontract agreement. The project requires expertise in clinical trial methodology, digital sensor validation, and regulatory science to meet the FDA’s standards for integrating novel digital health technologies into pharmaceutical development pipelines.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
